Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter — ultra-fast Hanzi study All 1,152 characters from the aioLingua manual Abstract • About • The 20 audio files ← aioLingua Chinese Online ← Chinese aioLingua PDF

Hepatitis C

Free Subscription Articles published in J Med Virol Retrieve available abstracts of 41 articles: HTML format

Single Articles

November 2025
1. ALKILANY LF, Alkilany SF, Gaber N, Farrag A, et al
   "Exploring Hepatitis C as a Relapse Risk Factor in Pediatric Acute Lymphoblastic Leukemia: A Study From a Resource-Limited Egyptian Setting".
   J Med Virol. 2025;97:e70683.
   PubMed     Abstract available
   
   
   
2. NABIH OS, Samiee MA, Tahoon MA, Abozeid E, et al
   Association of ANGPT2 and NOS3 Gene Variants With Esophageal Variceal Progression in HCV-Induced Cirrhosis.
   J Med Virol. 2025;97:e70686.
   PubMed     Abstract available
   
   
   
3. FAZLI P, Bakhtiari S, Jalilian FA, Teimoori A, et al
   Clinical and Immunological Impact of Occult Hepatitis B Virus Infection Among HIV-Infected Patients With and Without HCV Co-Infection in Iran: A Cross-Sectional Analysis.
   J Med Virol. 2025;97:e70715.
   PubMed     Abstract available
   
   
   
4. HUANG R, Ji F, Jiang Y, Li S, et al
   Sofosbuvir/Velpatasvir/Voxilaprevir Versus Sofosbuvir/Velpatasvir Plus Ribavirin in Patients With Hepatitis C Virus Genotype 3b and Compensated Cirrhosis: A Multicentre Randomized Controlled Trial.
   J Med Virol. 2025;97:e70709.
   PubMed     Abstract available
   
   
   
5. ABDEL-SAMIEE M, Aburaia G, Abdelsameea E, Fathy S, et al
   Solute Carrier Gene Polymorphism (SLC29A1) in Relation to Treatment Outcome and Hematological Changes in Chronic Hepatitis C Patients Treated With Direct Acting Antivirals Plus Ribavirin.
   J Med Virol. 2025;97:e70692.
   PubMed     Abstract available
   
   
   October 2025
6. SHI S, Zhai M, Wu B, Sun W, et al
   Mitochondrial Disruption in Viral-Mediated Neuronal Injury: A Mechanistic Perspective.
   J Med Virol. 2025;97:e70626.
   PubMed     Abstract available
   
   
   
7. YUNIHASTUTI E, Ophinni Y, Sari V, Adli I, et al
   Longitudinal Changes in Immune Biomarkers Following Direct-Acting Antiviral Therapy in HIV/HCV-Coinfected Individuals in Indonesia.
   J Med Virol. 2025;97:e70627.
   PubMed     Abstract available
   
   
   July 2025
8. PANG X, He Q, Huang J, Tang K, et al
   Epidemiological Trends and CD4+T Cell Recovery in HIV-1 Patients With HCV/HBV Co-Infection: A Retrospective Cohort Study in Southwest China (2003-2024).
   J Med Virol. 2025;97:e70465.
   PubMed     Abstract available
   
   
   June 2025
9. MISRA G, Gupta M, Singhal R, Qaisar S, et al
   Strategic Approach to Enhancing Diagnostic Precision: Optimizing Panel Size for HBV and HCV Viral Load Monitoring Kits.
   J Med Virol. 2025;97:e70437.
   PubMed     Abstract available
   
   
   March 2025
10. JIN Q, Zhou M, Sun M, Ning B, et al
    Global Temporal Trends in Mother-to-Child Transmission Disease Incidence Among Women of Child-Bearing Age: An Analysis of Global Burden of Disease Study 2021 Data.
    J Med Virol. 2025;97:e70283.
    PubMed     Abstract available
    
    
    
11. PONNUVEL S, Ali H, Prakash A, John Steve R, et al
    Superior Performance of Newly Developed Alinity Anti-HCV Next Assay in the Diagnosis of HCV Infection.
    J Med Virol. 2025;97:e70307.
    PubMed     Abstract available
    
    
    February 2025
12. LUZ E, Marques M, Arriaga MB, Campos LM, et al
    Risk Factors for Viral Coinfections in Blood Donors in Bahia, Brazil.
    J Med Virol. 2025;97:e70186.
    PubMed     Abstract available
    
    
    
13. ARSLAN N, Reuter B, Buech J, Lengauer T, et al
    Hepatitis C Virus Saint Petersburg Variant Detection With Machine Learning Methods.
    J Med Virol. 2025;97:e70169.
    PubMed     Abstract available
    
    
    December 2024
14. KAMBOJ S, Kumar M
    Global Origin and Spatiotemporal Spread of Hepatitis C Virus Epidemic Genotypes/Subtypes: A Complete Genome-Based Phylodynamic and Phylogeographic Analyses.
    J Med Virol. 2024;96:e70123.
    PubMed     Abstract available
    
    
    November 2024
15. CHU D, Oh YH, Sung H, Ko DH, et al
    Simple, direct amplification of RNA-containing paper discs for diagnosing the hepatitis C virus.
    J Med Virol. 2024;96:e29919.
    PubMed     Abstract available
    
    
    October 2024
16. TREVINO-NAKOURA A, Sepulveda-Crespo D, Bellon JM, Codina H, et al
    Diagnostic performance of dried blood spot hepatitis C virus core antigen testing for hepatitis C screening: A systematic review and meta-analysis.
    J Med Virol. 2024;96:e70018.
    PubMed     Abstract available
    
    
    September 2024
17. RZYMSKI P, Jibril AT, Rahmah L, Abarikwu SO, et al
    Is there still hope for the prophylactic hepatitis C vaccine? A review of different approaches.
    J Med Virol. 2024;96:e29900.
    PubMed     Abstract available
    
    
    August 2024
18. SAKR AA, Mohamed AA, Ahmed AE, Abdelhaleem AA, et al
    Biochemical implication of acetylcholine, histamine, IL-18, and interferon-alpha as diagnostic biomarkers in hepatitis C virus, coronavirus disease 2019, and dual hepatitis C virus-coronavirus disease 2019 patients.
    J Med Virol. 2024;96:e29857.
    PubMed     Abstract available
    
    
    July 2024
19. LI Y, Zeng T, Huang P, Tan W, et al
    Investigating the role of killer cell immunoglobulin-like receptors and human leukocyte antigen genetic variants in hepatitis C virus infection.
    J Med Virol. 2024;96:e29776.
    PubMed     Abstract available
    
    
    
20. CASTRO V, Calvo G, Oliveros JC, Perez-Del-Pulgar S, et al
    Hepatitis C virus-induced differential transcriptional traits in host cells after persistent infection elimination by direct-acting antivirals in cell culture.
    J Med Virol. 2024;96:e29787.
    PubMed     Abstract available
    
    
    June 2024
21. GUO JW, Ho HY, Dai CY, Chen YH, et al
    Single-tube, single-strip lateral flow assays utilizing loop-mediated isothermal amplification for simultaneous hepatitis B and C viral detection.
    J Med Virol. 2024;96:e29721.
    PubMed     Abstract available
    
    
    May 2024
22. LIU CH, Chang YP, Lee JY, Chen CY, et al
    Four weeks of off-treatment follow-up is sufficient to determine virologic responses at off-treatment week 12 in patients with hepatitis C virus infection receiving fixed-dose pangenotypic direct-acting antivirals.
    J Med Virol. 2024;96:e29675.
    PubMed     Abstract available
    
    
    
23. CHANG YP, Huang CB, Su TH, Liu CJ, et al
    Comparison of diagnostic performance among Abbott RealTime HCV Genotyping II, Abbott HCV Genotype plus RUO, and Roche Cobas HCV Genotyping assays for hepatitis C virus genotyping.
    J Med Virol. 2024;96:e29686.
    PubMed     Abstract available
    
    
    April 2024
24. 
    Retraction: "Small Interfering RNA Effectively Inhibits Protein Expression and Negative Strand RNA Synthesis From a Full-Length Hepatitis C Virus Clone".
    J Med Virol. 2024;96:e29574.
    PubMed     Abstract available
    
    
    March 2024
25. CHEN X, Dong S, Shi Y, Wu Z, et al
    Biosensor-based multiple cross displacement amplification platform for visual and rapid identification of hepatitis C virus.
    J Med Virol. 2024;96:e29481.
    PubMed     Abstract available
    
    
    
26. MIUMA S, Miyaaki H, Ichikawa T, Matsuzaki T, et al
    Non-liver-related mortality in the DAA era: Insights from post-SVR patients with and without previous HCC history.
    J Med Virol. 2024;96:e29432.
    PubMed     Abstract available
    
    
    February 2024
27. CHEN B, Xu B, Cui HY, Ma ZH, et al
    Comparison of effectiveness and cost of different HCV testing strategies in high-risk populations in China.
    J Med Virol. 2024;96:e29433.
    PubMed     Abstract available
    
    
    
28. LIU W, Li L, Yin M, Cao C, et al
    High-speed centrifugation rather than Lipoclear reagent can be used for removing the interference of lipemia on serological tests of infectious diseases: AIDS, hepatitis B, hepatitis C, and syphilis by chemiluminescent microparticle immunoassay.
    J Med Virol. 2024;96:e29385.
    PubMed     Abstract available
    
    
    
29. LIU Y, Kim ES, Guo H
    Hepatitis B virus-related hepatocellular carcinoma exhibits distinct intratumoral microbiota and immune microenvironment signatures.
    J Med Virol. 2024;96:e29485.
    PubMed     Abstract available
    
    
    January 2024
30. LI M, Wei Z, Su J, Wu X, et al
    Changing spectrum and mortality disparities of etiology of liver cirrhosis in Beijing, China.
    J Med Virol. 2024;96:e29405.
    PubMed     Abstract available
    
    
    
31. ADHIKARI A, Abayasingam A, Brasher NA, Kim HN, et al
    Characterization of antibody-dependent cellular phagocytosis in patients infected with hepatitis C virus with different clinical outcomes.
    J Med Virol. 2024;96:e29381.
    PubMed     Abstract available
    
    
    December 2023
32. ABDEL-SAMIEE M, Youssef MI, Elghamry F, Bazeed M, et al
    A multicentric and nationwide predictive study role of T cell sub-population in the prevalence and prognosis of cryoglobulinemia among genotype 4 chronic hepatitis C patients.
    J Med Virol. 2023;95:e29248.
    PubMed     Abstract available
    
    
    
33. NGARI JW, Leumi S, Han L, Liu C, et al
    Identification and characterization of Sofosbuvir-resistant mutations of hepatitis C virus genotype 3a replicon.
    J Med Virol. 2023;95:e29290.
    PubMed     Abstract available
    
    
    September 2023
34. PENG X, Shi Y, Zhang B, Xu C, et al
    Establishment of nucleic acid sensing pathways-based model in predicting response to immunotherapy and targeted drug in hepatitis virus-related hepatocellular carcinoma.
    J Med Virol. 2023;95:e29084.
    PubMed     Abstract available
    
    
    
35. LIU C, Guo M, Han L, Lu J, et al
    Construction and characterization of a new hepatitis C virus genotype 6a subgenomic replicon that is prone to render the sofosbuvir resistance.
    J Med Virol. 2023;95:e29103.
    PubMed     Abstract available
    
    
    August 2023
36. ADACHI E, Saito M, Kikuchi T, Ikeuchi K, et al
    Incidence of sexually transmitted hepatitis C virus infection among men who have sex with men in Japan from 2009 to 2023.
    J Med Virol. 2023;95:e29039.
    PubMed     Abstract available
    
    
    July 2023
37. LARA-AGUILAR V, Crespo-Bermejo C, Llamas-Adan M, Grande-Garcia S, et al
    HCV spontaneous clearers showed low senescence profile in people living with HIV under long ART.
    J Med Virol. 2023;95:e28955.
    PubMed     Abstract available
    
    
    
38. QU Y, Wang W, Xiao MZX, Zheng Y, et al
    The interplay between lipid droplets and virus infection.
    J Med Virol. 2023;95:e28967.
    PubMed     Abstract available
    
    
    March 2023
39. WU B, Tobe RG, Yan M, Lin H, et al
    Trends of Global Burden Related to HBV and HCV from 1990 to 2019: An Age-Period-Cohort Analysis.
    J Med Virol. 2023 Mar 11. doi: 10.1002/jmv.28663.
    PubMed     Abstract available
    
    
    
40. PISATURO M, Alessio L, Starace M, Macera M, et al
    CHARACTERIZATION OF HEPATITIS VIRUS CO-INFECTIONS IN A COHORT OF IMMIGRANTS LIVING IN SOUTHERN ITALY.
    J Med Virol. 2023 Mar 10. doi: 10.1002/jmv.28665.
    PubMed     Abstract available
    
    
    
41. FENG Z, Huang P, Zhang J, Xia X, et al
    KIR2DL4/HLA-G polymorphisms were associated with HCV infection susceptibility among Chinese high-risk population.
    J Med Virol. 2023 Mar 8. doi: 10.1002/jmv.28645.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis C is free of charge.